Intra-Cellular Therapies (“ITCI”) Stock Soars While Key Clinical Data Not Presented to Shareholders Looks Highly Disappointing

(July 15th, 2015) Biotech stocks have been on fire. And for good reason as numerous life-saving discoveries have come out of small, previously-unknown firms, making their owners rich many times over. But beneath the surface, a number of troubling drug development companies have caught the attention of investors with clinical data that’s dubious at best. With seemingly endless amounts of optimism, these biotech stocks have ridden the wave of investor enthusiam even when the data doesn’t look as promising as the market caps seem to indicate.

Read more

All You Ever Wanted to Know About Retrophin But Were Afraid to Ask

(June 2nd, 2014) Humans, like atoms, abhor unsteady states of existence. Just like electron transport gravitates towards a steady-state, people gravitate towards peaceful lands and away from battleground areas. Read more

Know What to Buy When Putin Comes Knocking

So Putin rolls a bunch of tanks up to the Ukrainian border and the market slides a percent or so. In any other market that would be considered a yawn. But here in the good ‘ol US of A, where the average active investor can barely remember the dog days of ’08, few traders seem to have the skill set necessary to maneuver in a down market. Having done this for 20+ years, I thought it would be helpful to share my trading tips for when war comes knocking.
Read more

Little Bear Investments LLC Participates in ImageWare Systems Inc. $7 Million Private Placement

Monday November 17, 2003, 9:00 am ET

NEW YORK, November 17 — Little Bear Investments LLC (“Little Bear”) announced today that it has participated in a $7 million private placement of common stock and warrants of ImageWare Systems, Inc. (Amex: IW – “IWS”). As part of the transaction, IWS expects to pay off all of its outstanding 12.5% convertible secured debt. For more information regarding the private placement visit IWS’ web site at

Zachary Prensky, managing member of the Little Bear, commented that: “With the 12.5% convertible notes retired, the corresponding interest payments eliminated, and the continued growth of IWS’ core business, it is our strong belief that the company can rapidly turn cash flow positive. This type of restructuring, taking a debt-laden cash flow negative business and turning it around, is one of the core focuses of Little Bear. We are pleased to have participated in this transaction, brought to us by the professional bankers at Sands Brothers, and continue to look to deploy capital in similar transactions in both the private as well as the public marketplaces.”

About ImageWare Systems

ImageWare Systems, Inc. (AMEX:IW) is the leading global developer of digital imaging, identification and biometric software solutions for the corporate, government, law enforcement, professional photography, transportation, education and healthcare markets, among others. ImageWare’s secure credential and biometric product lines are used to produce ID cards, driver licenses, passports, national medical health cards, national IDs and more. The Company’s law enforcement and biometric product lines provide the public safety market with booking, investigative and identification solutions that can be accessed and shared via PC, Web and wireless platforms. ImageWare’s professional digital imaging product line provides professional photographers with automated, in-studio and mobile solutions to facilitate the transition from film-based photography to digital imaging. Founded in 1987, ImageWare is headquartered in San Diego, with offices in Canada, Europe and Asia.

About Little Bear

Little Bear Investments, located in the heart of Midtown Manhattan, is a merchant bank that focuses on investing in both public and private companies. Our broad range of investment experience includes: tender offers, private placements, PIPE’s, reverse mergers and bankruptcy auctions. Little Bear also offers financial, operational and strategic advisory services. Working with companies large and small, we bring the same disciplined approach to our clients as we do to businesses in which we have deployed our own capital.

If you have any questions regarding this press release, please contact Zachary Prensky at or at 212-946-2736.

” Concentration is my motto – first honesty, then industry, then concentration. ” Andrew Carnegie